Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Detection of DNA modifications by the 32P-postlabelling assay.

Phillips DH.

Mutat Res. 1997 Aug 1;378(1-2):1-12. Review.

PMID:
9288880
2.

Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.

Randerath K, Liehr JG, Gladek A, Randerath E.

IARC Sci Publ. 1989;(96):189-205. Review.

PMID:
2509347
4.

32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.

Randerath K, Randerath E.

J UOEH. 1989 Mar 20;11 Suppl:368-86. Review.

PMID:
2664950
5.

Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.

Kovács K, Anna L, Rudnai P, Schoket B.

Mutat Res. 2011 Mar 18;721(1):95-100. doi: 10.1016/j.mrgentox.2010.12.012. Epub 2011 Jan 13.

PMID:
21237286
6.

32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.

Talaska G, Roh JH, Getek T.

J Chromatogr. 1992 Sep 16;580(1-2):293-323. Review.

PMID:
1400827
7.

Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.

Shields PG, Kato S, Bowman ED, Petruzzelli S, Cooper DP, Povey AC, Weston A.

IARC Sci Publ. 1993;(124):243-54.

PMID:
8225491
8.

32P-postlabeling analysis of DNA adducts.

Phillips DH, Hewer A, Arlt VM.

Methods Mol Biol. 2005;291:3-12.

PMID:
15502206
10.

³²P-postlabelling for the sensitive detection of DNA adducts.

Jones NJ.

Methods Mol Biol. 2012;817:183-206. doi: 10.1007/978-1-61779-421-6_10.

PMID:
22147574
11.

Monitoring carcinogen actions on DNA by 32P-postlabeling.

Randerath K, Randerath E.

Princess Takamatsu Symp. 1990;21:317-28. Review.

PMID:
2134685
12.

Comparison of immunoaffinity chromatography enrichment and nuclease P1 procedures for 32P-postlabelling analysis of PAH-DNA adducts.

Randerath K, Sriram P, Moorthy B, Aston JP, Baan RA, van den Berg PT, Booth ED, Watson WP.

Chem Biol Interact. 1998 Mar 12;110(1-2):85-102.

PMID:
9566727
13.
15.

Measurement of DNA adducts in humans after complex mixture exposure.

Dale CM, Garner RC.

Food Chem Toxicol. 1996 Sep;34(9):905-19. Review.

PMID:
8972883
16.

Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.

Godschalk RW, Vermeer IT, Kriek E, Floot B, Schilderman PA, Moonen EJ, Kleinjans JC, van Schooten FJ.

Chem Biol Interact. 1997 Apr 18;104(1):41-54.

PMID:
9158694
17.

DNA repair in human cells: quantitative assessment of bulky anti-BPDE-DNA adducts by non-competitive immunoassays.

Venkatachalam S, Denissenko M, Wani AA.

Carcinogenesis. 1995 Sep;16(9):2029-36.

PMID:
7554050
18.

Biomonitoring human exposure to environmental carcinogenic chemicals.

Farmer PB, Sepai O, Lawrence R, Autrup H, Sabro Nielsen P, Vestergård AB, Waters R, Leuratti C, Jones NJ, Stone J, Baan RA, van Delft JH, Steenwinkel MJ, Kyrtopoulos SA, Souliotis VL, Theodorakopoulos N, Bacalis NC, Natarajan AT, Tates AD, Haugen A, Andreassen A, Ovrebø S, Shuker DE, Amaning KS, Castelain P, et al.

Mutagenesis. 1996 Jul;11(4):363-81.

19.

Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.

Culp SJ, Roberts DW, Talaska G, Lang NP, Fu PP, Lay JO Jr, Teitel CH, Snawder JE, Von Tungeln LS, Kadlubar FF.

Mutat Res. 1997 Aug 1;378(1-2):97-112.

PMID:
9288889
20.

32P-postlabelling methods for cyclic DNA adducts.

Watson WP, Crane AE, Steiner S.

IARC Sci Publ. 1993;(124):255-62.

PMID:
8225493
Items per page

Supplemental Content

Write to the Help Desk